SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    L. Milani, L. Leitsalu, A. Metspalu, An epidemiological perspective of personalized medicine: the Estonian experience, Journal of Internal Medicine, 2015, 277, 2
  2. 2
    Xianxu Zeng, Zhenying Ban, Jing Cao, Wei Zhang, Tianjiao Chu, Dongmei Lei, Yanmin Du, Association of FTO Mutations with Risk and Survival of Breast Cancer in a Chinese Population, Disease Markers, 2015, 2015, 1

    CrossRef

  3. 3
    P. Economopoulou, G. Dimitriadis, A. Psyrri, Beyond BRCA: New hereditary breast cancer susceptibility genes, Cancer Treatment Reviews, 2015, 41, 1, 1

    CrossRef

  4. 4
    Paraskevi Apostolou, Florentia Fostira, Myrto Papamentzelopoulou, Maria Michelli, Christos Panopoulos, George Fountzilas, Irene Konstantopoulou, Gerassimos E. Voutsinas, Drakoulis Yannoukakos, CHEK2 c.1100delC allele is rarely identified in Greek breast cancer cases, Cancer Genetics, 2015, 208, 4, 129

    CrossRef

  5. 5
    N. N. Basu, L. Barr, G. L. Ross, D. G. Evans, Contralateral Risk-Reducing Mastectomy: Review of Risk Factors and Risk-Reducing Strategies, International Journal of Surgical Oncology, 2015, 2015, 1

    CrossRef

  6. 6
    Fatima Aloraifi, Trudi McDevitt, Rui Martiniano, Jonah McGreevy, Russell McLaughlin, Chris M. Egan, Nuala Cody, Marie Meany, Elaine Kenny, Andrew J. Green, Daniel G. Bradley, James G. Geraghty, Adrian P. Bracken, Detection of novel germline mutations for breast cancer in non-BRCA1/2 families, FEBS Journal, 2015, 282, 16
  7. 7
    Fatima Aloraifi, Michael R. Boland, Andrew J. Green, James G. Geraghty, Gene analysis techniques and susceptibility gene discovery in non-BRCA1/BRCA2 familial breast cancer, Surgical Oncology, 2015, 24, 2, 100

    CrossRef

  8. 8
    Suzanna L Arcand, Mohammed R Akbari, Anne-Marie Mes-Masson, Diane Provencher, William D Foulkes, Steven A Narod, Patricia N Tonin, Germline TP53 mutational spectrum in French Canadians with breast cancer, BMC Medical Genetics, 2015, 16, 1

    CrossRef

  9. 9
    Carolina Ellberg, Helena Jernström, Per Broberg, Åke Borg, Håkan Olsson, Impact of a paternal origin of germline BRCA1/2 mutations on the age at breast and ovarian cancer diagnosis in a Southern Swedish cohort, Genes, Chromosomes and Cancer, 2015, 54, 1
  10. 10
    Laure Dossus, Patrick R Benusiglio, Lobular breast cancer: incidence and genetic and non-genetic risk factors, Breast Cancer Research, 2015, 17, 1, 37

    CrossRef

  11. 11
    N. N. Basu, S. Ingham, J. Hodson, F. Lalloo, M. Bulman, A. Howell, D. G. Evans, Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis, Familial Cancer, 2015,

    CrossRef

  12. 12
    Dongquan Chen, Yufeng Li, Lizhong Wang, Kai Jiao, SEMA6D Expression and Patient Survival in Breast Invasive Carcinoma, International Journal of Breast Cancer, 2015, 2015, 1

    CrossRef

  13. 13
    Burak Yılmaz, Catherine Moroski-Erkul, Omer Hatipoglu, Esra Gunduz, Debmalya Barh, Mehmet Gunduz, Noninvasive Molecular Markers in Gynecologic Cancers, 2015,

    CrossRef

  14. 14
    Aneta Bąk, Hanna Janiszewska, Anna Junkiert-Czarnecka, Marta Heise, Maria Pilarska-Deltow, Ryszard Laskowski, Magdalena Pasińska, Olga Haus, A risk of breast cancer in women - carriers of constitutional CHEK2 gene mutations, originating from the North - Central Poland, Hereditary Cancer in Clinical Practice, 2014, 12, 1, 10

    CrossRef

  15. 15
    Suzanne M. Mahon, Breast Cancer Risk Associated With <i>CHEK2</i> Mutations, Oncology Nursing Forum, 2014, 41, 6, 692

    CrossRef

  16. 16
    Susan Hiraki, Erica S. Rinella, Freya Schnabel, Ruth Oratz, Harry Ostrer, Cancer Risk Assessment Using Genetic Panel Testing: Considerations for Clinical Application, Journal of Genetic Counseling, 2014, 23, 4, 604

    CrossRef

  17. 17
    Muy-Kheng M. Tea, Regina Kroiss, Daniela Muhr, Christine Fuerhauser-Rappaport, Peter Oefner, Teresa M. Wagner, Christian F. Singer, Central European BRCA2 mutation carriers: Birth cohort status correlates with onset of breast cancer, Maturitas, 2014, 77, 1, 68

    CrossRef

  18. 18
    Aurélie Ayme, Valeria Viassolo, Elisabetta Rapiti, Gérald Fioretta, Hyma Schubert, Christine Bouchardy, Pierre O. Chappuis, Simone Benhamou, Determinants of genetic counseling uptake and its impact on breast cancer outcome: a population-based study, Breast Cancer Research and Treatment, 2014, 144, 2, 379

    CrossRef

  19. 19
    Eugenia Yiannakopoulou, Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: clinical implications, Cellular Oncology, 2014, 37, 1, 1

    CrossRef

  20. 20
    Amy L Masson, Bente A Talseth-Palmer, Tiffany-Jane Evans, Desma M Grice, Garry N Hannan, Rodney J Scott, Expanding the genetic basis of copy number variation in familial breast cancer, Hereditary Cancer in Clinical Practice, 2014, 12, 1, 15

    CrossRef

  21. 21
    D. S. Gogarty, M. P. Farrell, D. J. Gallagher, Genetic testing and interpretive complexity: a BRCA1 gene mutation example, Irish Journal of Medical Science (1971 -), 2014,

    CrossRef

  22. 22
    Amélie Véron, Sophie Blein, David G Cox, Genome-wide association studies and the clinic: a focus on breast cancer, Biomarkers in Medicine, 2014, 8, 2, 287

    CrossRef

  23. 23
    Anna P. Sokolenko, Daria R. Bulanova, Aglaya G. Iyevleva, Svetlana N. Aleksakhina, Elena V. Preobrazhenskaya, Alexandr O. Ivantsov, Ekatherina Sh. Kuligina, Natalia V. Mitiushkina, Evgeny N. Suspitsin, Grigoriy A. Yanus, Olga A. Zaitseva, Olga S. Yatsuk, Alexandr V. Togo, Poojitha Kota, J. Michael Dixon, Alexey A. Larionov, Sergey G. Kuznetsov, Evgeny N. Imyanitov, High prevalence of GPRC5A germline mutations in BRCA1-mutant breast cancer patients, International Journal of Cancer, 2014, 134, 10
  24. 24
    Jon Zugazagoitia, Pedro Pérez-Segura, Arancha Manzano, Ignacio Blanco, Ana Vega, Ana Custodio, Alex Teulé, Laura Fachal, Beatriz Martínez, Rogelio González-Sarmiento, Juan Jesús Cruz-Hernández, Isabel Chirivella, Vicente Garcés, Pilar Garre, Atocha Romero, Trinidad Caldés, Eduardo Díaz-Rubio, Miguel de la Hoya, Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers, Breast Cancer Research and Treatment, 2014, 148, 2, 415

    CrossRef

  25. 25
    Irene R. Rainville, Huma Q. Rana, Next-Generation Sequencing for Inherited Breast Cancer Risk: Counseling through the Complexity, Current Oncology Reports, 2014, 16, 3

    CrossRef

  26. 26
    Valeria D'Argenio, Maria Valeria Esposito, Jean Ann Gilder, Giulia Frisso, Francesco Salvatore, Should a BRCA2 stop codon human variant, usually considered a polymorphism, be classified as a predisposing mutation?, Cancer, 2014, 120, 10
  27. 27
    Brandon M. Welch, Kensaku Kawamoto, Brian Drohan, Kevin S. Hughes, Clinical Decision Support, 2014,

    CrossRef

  28. 28
    Richard E. Jones, Kristin H. Lopez, Human Reproductive Biology, 2014,

    CrossRef

  29. 29
    Olafur A. Stefansson, Manel Esteller, Epigenetic Modifications in Breast Cancer and Their Role in Personalized Medicine, The American Journal of Pathology, 2013, 183, 4, 1052

    CrossRef

  30. 30
    Arkadiusz Piotrowski, Jing Xie, Ying F Liu, Andrzej B Poplawski, Alicia R Gomes, Piotr Madanecki, Chuanhua Fu, Michael R Crowley, David K Crossman, Linlea Armstrong, Dusica Babovic-Vuksanovic, Amanda Bergner, Jaishri O Blakeley, Andrea L Blumenthal, Molly S Daniels, Howard Feit, Kathy Gardner, Stephanie Hurst, Christine Kobelka, Chung Lee, Rebecca Nagy, Katherine A Rauen, John M Slopis, Pim Suwannarat, Judith A Westman, Andrea Zanko, Bruce R Korf, Ludwine M Messiaen, Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas, Nature Genetics, 2013, 46, 2, 182

    CrossRef

  31. 31
    Mohammad Mahdi Kooshyar, Mohammadreza Nassiri, Morteza Mahdavi, Mohammad Doosti, Amirreza Parizadeh, Identification of Germline BRCA1 Mutations among Breast Cancer Families in Northeastern Iran, Asian Pacific Journal of Cancer Prevention, 2013, 14, 7, 4339

    CrossRef

  32. 32
    SL Ingham, J Warwick, H Byers, F Lalloo, WG Newman, DGR Evans, Is multiple SNP testing in BRCA2 and BRCA1 female carriers ready for use in clinical practice? Results from a large Genetic Centre in the UK, Clinical Genetics, 2013, 84, 1
  33. 33
    R. Lopez, P. Agullo, R. Lakshmanaswamy, Links between obesity, diabetes and ethnic disparities in breast cancer among Hispanic populations, Obesity Reviews, 2013, 14, 8
  34. 34
    V.M. Garrisi, S. Tommasi, A. Facchiano, I. Bongarzone, M. De Bortoli, M. Cremona, V. Cafagna, I. Abbate, A. Tufaro, M. Quaranta, A. Paradiso, Proteomic profile in familial breast cancer patients, Clinical Biochemistry, 2013, 46, 3, 259

    CrossRef

  35. 35
    Gert Matthijs, Isabelle Huys, Geertrui Van Overwalle, Dominique Stoppa-Lyonnet, The European BRCA patent oppositions and appeals: coloring inside the lines, Nature Biotechnology, 2013, 31, 8, 704

    CrossRef

  36. You have free access to this content36
    FSM Hilbers, MPG Vreeswijk, CJ van Asperen, P Devilee, The impact of next generation sequencing on the analysis of breast cancer susceptibility: a role for extremely rare genetic variation?, Clinical Genetics, 2013, 84, 5
  37. 37
    Brandon Welch, Kensaku Kawamoto, The Need for Clinical Decision Support Integrated with the Electronic Health Record for the Clinical Application of Whole Genome Sequencing Information, Journal of Personalized Medicine, 2013, 3, 4, 306

    CrossRef

  38. 38
    Paraskevi Apostolou, Athanassios Vratimos, Florentia Fostira, Breast Cancer Susceptibility Genes, eLS,